NCT00593294 - Oral Contraceptive and Cardiovascular Risk in PCOS | Biotech Hunter

Enrollment

150

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

September 30, 2007

Study Completion Date

December 31, 2007

Conditions

Polycystic Ovary Syndrome

Interventions

BEHAVIORAL

Physical exercise

45 minutes each day for three times/week for 6 months

DRUG

OC - Drospirenone plus Ethynylestradiol

1 cp for 21 days each month for 6 months of OC (Drospirenone 3 mg plus Ethynylestradiol 30 microgram = Yasmin, Schering, Milan, Italy)

DIETARY_SUPPLEMENT

Vitamin, polyvitamins tablets

Tablet of vitamin 1cp for 21 days each month for 6 months

Trial Locations (1)

"Department of Molecular and Clinical Endocrinology and Oncology, University Federico II", Naples

All Listed Sponsors

lead

Federico II University

OTHER